Modelling kidney disease with CRISPR-mutant kidney organoids derived from human pluripotent epiblast spheroids

利用源自人类多能性外胚层球体的CRISPR突变肾脏类器官构建肾脏疾病模型

阅读:14
作者:Benjamin S Freedman   ,Craig R Brooks,Albert Q Lam,Hongxia Fu,Ryuji Morizane,Vishesh Agrawal ,Abdelaziz F Saad,Michelle K Li,Michael R Hughes,Ryan Vander Werff,Derek T Peters ,Junjie Lu ,Anna Baccei ,Andrew M Siedlecki,M Todd Valerius,Kiran Musunuru ,Kelly M McNagny,Theodore I Steinman,Jing Zhou,Paul H Lerou ,Joseph V Bonventre

Abstract

Human-pluripotent-stem-cell-derived kidney cells (hPSC-KCs) have important potential for disease modelling and regeneration. Whether the hPSC-KCs can reconstitute tissue-specific phenotypes is currently unknown. Here we show that hPSC-KCs self-organize into kidney organoids that functionally recapitulate tissue-specific epithelial physiology, including disease phenotypes after genome editing. In three-dimensional cultures, epiblast-stage hPSCs form spheroids surrounding hollow, amniotic-like cavities. GSK3β inhibition differentiates spheroids into segmented, nephron-like kidney organoids containing cell populations with characteristics of proximal tubules, podocytes and endothelium. Tubules accumulate dextran and methotrexate transport cargoes, and express kidney injury molecule-1 after nephrotoxic chemical injury. CRISPR/Cas9 knockout of podocalyxin causes junctional organization defects in podocyte-like cells. Knockout of the polycystic kidney disease genes PKD1 or PKD2 induces cyst formation from kidney tubules. All of these functional phenotypes are distinct from effects in epiblast spheroids, indicating that they are tissue specific. Our findings establish a reproducible, versatile three-dimensional framework for human epithelial disease modelling and regenerative medicine applications.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。